EASTWIN was established on November 22, 2012 with a registered capital of RMB 5 million. It was jointly funded and founded by Beijing EASTWIN Biotechnology Co., Ltd., Suzhou Oriza Holdings Corporation and the management team. Since September 2016, it has joined NKY Medical Group (stock: 300109).
EASTWIN is mainly engaged in life science equipment, medical equipment, molecular laboratory equipment and other related businesses, integrating R&D, design, production, sales and service. The company has standardized production facilities, advanced management concepts, and excellent corporate culture. Especially in the design, manufacture, application and service of PCR instruments (thermal cycler), we have a professional team with more than 20 years of experience. It is one of the earliest Peltier technology PCR instrument design and manufacturing teams in China. Known as the PCR instrument expert by the industry.
Since our main products ETC811 and ETC821 thermal cyclers were launched in 2013, they have been praised and favored by customers for their stable quality and high-quality service. They have become one of the mainstream instruments in China's molecular biology laboratory, with a market share exceeding 10%. Application areas include teaching, scientific research, clinical testing, CDC, etc. Teaching and research users include Tsinghua University, Peking University, Zhejiang University, Shanghai Jiaotong University, Fudan University, etc. Clinical users include Yaneng Biosciences, Hybribio, CapitalBio, BGI, GENEWIZ, GeneScript, SangonBiotech, Tellgene, etc. Since 2019, EASTWIN has successively launched new products such as fluorescent quantitative PCR instrument, POCT nucleic acid detector, isothermal PCR instrument, industrial automated PCR, automated workstation cooling unit, and multi-head PCR thermal cycler. It has received strong attention from customers at the Analytica Shanghai Exhibition and the Shanghai Fair. The qPCR have been sold to South Korea, Singapore, Southeast Asia, South America and other countries and regions to combat Covid-19.
EASTWIN will continue to work hard in the life science instrument industry to provide customers with more and more products and services.

Brand: EASTWIN (foreign), 东胜·龙 (China)

         Development History        

2012.11  Our company is founded in Suzhou Industrial Park, with the area of 2200 square meters.
              Mainly engaged in the research, development, production, sales and services of life sciences instruments.
2013       ETC811 PCR Thermocycler listing
2014.2    Through TÜV SÜD certification ISO9001/13485 certification
2014.4    Obtain medical device production license (6840)
2014.8    Get the recognition of "national high and new technology enterprise"
2015.4    ETC811 PCR instrument obtained the registration certificate of class II equipments (Su Jun note 20152400297)
2016.9    Joined the NKY medical group(Stock Code: 300109)
2017.12  The annual sales volume of ETC811 PCR instrument exceeded 1,000 units.
2018.5    Transilluminator and electronic ice box are on the market
2018.9    Mini Centrifuge are on the market
2018.10  ETC821 Thermal cycler was launched
2019.5    eQ162H constant temperature qPCR was launched
2019.10  eQ162C qPCR was launched
2020.3    eQ162CP/eQ164CP series qPCR was launched
2020.4    eQ162CP/eQ164CP series qPCR obtained CE certificate
2020.4    ETC821/821M series thermal cycler obtained CE certificate   
2020.10  ETC821M、ETC821M-384、ETC821M-Insitu、ETC811Plus、ETC811Plus-384 Thermal Cycler obtained class II 6840 medical device registration certificate (Su Xie Note 20202221109)
2021.4   eATC Automatic Thermal Cycler was launched
2021.11  ETC821D Double-block Thermal Cycler obtained CE certificate  
2021.11  ETC821D Double-block Thermal Cycler was launched
2021.12  eQ9600 series qPCR to be launched